If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Share Dealing

19 May 2023 09:30

RNS Number : 0283A
Hyve Group PLC
19 May 2023
 

19 May 2023

Hyve Group plc

(the "Company")

 

Director/PDMR Share Dealing

 

On 18 May 2023, the following persons discharging material responsibilities in connection with their roles as directors of the Company, Mark Shashoua and John Gulliver, acquired 2,611,040 and 1,365,207 ordinary shares of 10 pence each in the Company, respectively, in connection with the vesting and exercise of certain share awards granted under the Company's Performance Share Plan 2014, Deferred Share Bonus Plan and Value Creation Plan 2021.

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

Mark Shashoua

2. Reason for the notification

a) Position/status

Chief Executive Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Hyve Group plc

b) LEI

549300ZOQOW485BCD047

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence

b) Identification code

ISIN:GB00BKP36R26

c) Nature of the transaction

Vesting and exercise of share awards in respect of 461,668 ordinary shares with an exercise price of £0,10 pence per share under the Performance Share Plan 2014, the vesting of awards in respect of 364,732 ordinary shares under the Deferred Share Bonus Plan, and the vesting of awards in respect of 1,784,640 ordinary shares under the Value Creation Plan 2021.

d) Price(s) and volume(s)

Price(s)

Volume(s)

£0.10

461,668

Nil

364,732

£1.21

1,784,640

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

18 May 2023

g) Place of the transaction

Outside a trading venue

 

 

1. Details of the person discharging managerial responsibilities/person closely associated

 

a) Name

John Gulliver

2. Reason for the notification

a) Position/status

Chief Financial Officer

b) Initial notification / Amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Hyve Group plc

b) LEI

549300ZOQOW485BCD047

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument

Ordinary Shares of 10 pence

b) Identification code

ISIN:GB00BKP36R26

c) Nature of the transaction

Vesting and exercise of share awards in respect of 221,450 ordinary shares with an exercise price of £0,10 pence per share under the Performance Share Plan 2014, the vesting of awards in respect of 174,953 ordinary shares under the Deferred Share Bonus Plan, and the vesting of awards in respect of 968,804 ordinary shares under the Value Creation Plan 2021.

d) Price(s) and volume(s)

Price(s)

Volume(s)

£0.10

221,450

Nil

174,953

£1.21

968,804

e) Aggregated information:

i. Aggregated volume

ii. price

N/A

f) Date of the transaction

18 May 2023

g) Place of the transaction

Outside a trading venue

 

 

 

For further information please contact:

 

Hyve Group plc

Alice Rivers (Company Secretary)

 

Tel: +44 (0)20 3545 9558

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKCBDFBKKQPD
Date   Source Headline
22nd Feb 20231:42 pmRNSForm 8.3 - HYVE GROUP PLC
22nd Feb 202311:54 amRNSForm 8.3 - Hyve Group Plc
22nd Feb 202311:35 amRNSForm 8.3 - Hyve Group plc
22nd Feb 202311:16 amGNWForm 8.3 - Hyve Group Plc
22nd Feb 202310:46 amRNSForm 8.5 (EPT/RI)
22nd Feb 202310:44 amRNSForm 8.5 (EPT/RI) - Hyve Group PLC
22nd Feb 202310:08 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - HYVE GROUP PLC - Ordinary Shares
21st Feb 20236:22 pmRNSForm 8.3 - Hyve Group PLC
21st Feb 20232:37 pmRNSForm 8.3 - Hyve Group PLC
21st Feb 202311:20 amRNSStatement re Possible Offer
9th Feb 20231:00 pmRNSStandard form for notification of major holdings
6th Feb 20237:00 amRNSNotice of investor days and HY23 trading update
1st Feb 20231:00 pmRNSAnnouncement of Results of Annual General Meeting
30th Jan 20234:00 pmRNSDirector/PDMR Shareholding
27th Jan 20237:00 amRNSAppointment of Non-Executive Director
3rd Jan 202310:30 amRNSPublication of Annual Report and Notice of AGM
14th Dec 202210:01 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSPreliminary Results
30th Nov 202211:25 amRNSStandard form for notification of major holdings
21st Nov 202211:30 amRNSNotice of Full Year Results
12th Oct 20223:46 pmRNSStandard form for notification of major holdings
6th Oct 20229:34 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSPre-close FY22 trading update and Turkey disposal
4th Oct 20229:54 amRNSDirector Declaration
3rd Oct 20224:41 pmRNSSecond Price Monitoring Extn
3rd Oct 20224:35 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSBlock listing six monthly return
3rd Oct 20227:00 amRNSRefinancing of debt facilities and current trading
13th Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSResignation of Non-Executive Director
19th Jul 20227:00 amRNSManagement buy-out of Ukrainian business
27th Jun 20227:00 amRNSTrading Update
24th Jun 20229:58 amRNSHolding(s) in Company
1st Jun 20229:20 amRNSHolding(s) in Company
30th May 202210:22 amRNSStandard form for notification
24th May 20227:00 amRNS2022 Interim Results
20th May 20224:08 pmRNSStandard form for notification of major holdings
17th May 20221:33 pmRNSStandard form for notification of major holdings
16th May 20221:26 pmRNSStandard form for notification of major holdings
11th May 20224:38 pmRNSPUBLICATION OF CIRCULAR
25th Apr 202210:06 amRNSGeneral Meeting Results – Update Statement
14th Apr 20229:06 amRNSNotice of Half Year Results
6th Apr 20227:01 amRNSTrading Update
6th Apr 20227:00 amRNSProposed Disposal of Russian Business
1st Apr 20227:00 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
17th Mar 20225:45 pmRNSHolding(s) in Company
15th Mar 20224:51 pmRNSUpdate on Board review of Russian business
14th Mar 20225:52 pmRNSHolding(s) in Company
11th Mar 20227:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.